Last updated: August 15, 2024
Sponsor: Insel Gruppe AG, University Hospital Bern
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cancer
Vascular Diseases
Musculoskeletal Diseases
Treatment
Comprehensive disease-specific rehabilitation
Clinical Study ID
NCT06516172
2024-00480
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients aged 18 years and older with a chronic non-communicable disease
Signed general informed consent
Referral to a comprehensive disease-specific rehabilitation program
Exclusion
Exclusion Criteria:
- Refuted or missing general informed consent for further use of health-related dataand samples.
Study Design
Total Participants: 30000
Treatment Group(s): 1
Primary Treatment: Comprehensive disease-specific rehabilitation
Phase:
Study Start date:
December 01, 2020
Estimated Completion Date:
December 31, 2030
Study Description
Connect with a study center
Berner Reha Centre, Centre for Rehabilitation & Sports Medicine, Insel Group
Heiligenschwendi, Bern 3625
SwitzerlandActive - Recruiting
Reha Inselspital, Bern University Hospital, Centre for Rehabilitation & Sports Medicine, Insel Group
Bern, 3010
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.